How will RFK Jr’s American dream for vaccines play out?
Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump administration.
Business & Regulation
Bavarian Nordic nets $160m from priority review voucher sale
FDA creates new priority review voucher scheme to boost US interests
Trump’s push to onshore pharma manufacturing clouded by ‘lack of clarity’
iTeos to shut down following $2bn GSK-partnered TIGIT asset failure
HHS sets “most favoured nation” pricing targets for drug makers
Regeneron buys bankrupt 23andMe for $256m
Novo Nordisk’s CEO to step down as weight loss market share plummets
